Cao, Meng <br/><br/>
Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells.  [electronic resource] 

 -  Pathology, research and practice  Nov 2019 
 - 152621 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1618-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.prp.2019.152621  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Drug Resistance, Neoplasm--physiology<br/>Female<br/>Humans<br/>Protein Tyrosine Phosphatase, Non-Receptor Type 11--metabolism<br/>Up-Regulation<br/>Uterine Cervical Neoplasms--enzymology